T7 RNA polymerase is the workhorse of in vitro transcription: a single-subunit enzyme from bacteriophage T7 that initiates at its own promoter sequence and needs nothing else to make RNA from a DNA template. It is what sits behind a guide RNA made in-house, a labelled probe, a self-amplifying construct and every messenger RNA process at any scale. Buying it looks like buying a catalogue reagent until the volumes rise, at which point grade, unit definition and supply become the whole question.
What the enzyme does, and why the promoter matters
The polymerase recognises a short double-stranded promoter and transcribes downstream of it, which is why the template rather than the enzyme usually decides the outcome. A linear template cut cleanly at the end of the sequence gives a defined product; a nicked or incompletely digested plasmid gives a population of lengths. The enzyme is also happy to add untemplated bases at the end and to copy the product back on itself, which is the origin of much of the double-stranded RNA that downstream processes then have to remove. None of that is a defect in the enzyme lot: it is the chemistry, and it is why the specification of the template belongs in the same conversation as the specification of the enzyme.
Grades, units and what a unit actually measures
A unit of T7 RNA polymerase is defined by each supplier against its own assay, typically the incorporation of a nucleotide into acid-insoluble product per minute at a stated temperature on a stated template. Two enzymes quoted at the same units per microlitre are therefore not necessarily interchangeable, and the comparison that matters is yield of your product from your template under your conditions. Concentration, glycerol content and storage buffer affect how the enzyme behaves in a large reaction rather than a tube, and a high-concentration format is worth paying for once the reaction volume stops being a laboratory volume.
Mutant and thermostable variants
Engineered variants exist for specific problems: higher thermostability so the reaction can run hotter and the template stay linear, altered nucleotide selectivity for modified bases, and mutants that produce less double-stranded by-product. Each trades something, usually absolute yield or cost. Choose the variant by the problem you actually have, and be sceptical of a claim that a variant fixes by-product formation without a measurement on a template like yours, because the by-product depends on the sequence at the end of the template as much as on the enzyme.
Buying for in vitro transcription at scale
At scale the questions are supply rather than catalogue: lot size, lot-to-lot consistency data, whether the supplier will reserve material, and whether an animal-origin-free and later a compliant manufacturing grade exists in the same product line so a process does not have to be re-developed when it moves. If the product is destined for clinical material the relevant framework is the manufacturing and control expectation for the therapy, not the enzyme's research specification, and the documentation the supplier can provide becomes a selection criterion in its own right.
Questions people ask about t7 rna polymerase
What is a unit of T7 RNA polymerase?
An activity defined by the supplier's own incorporation assay, not an international standard. Compare enzymes on RNA yield from your own template rather than on units per microlitre.
Do I need a GMP grade enzyme?
Only if the RNA is destined for material given to a person or an animal in a regulated study. For research and process development a high-quality research grade is the right purchase, provided the supplier offers a compliant grade in the same line for later.
Why is my in vitro transcription yield low?
Usually the template rather than the enzyme: incomplete linearisation, a truncated or damaged promoter, contaminating nuclease, or magnesium and nucleotide concentrations out of balance. Check the template on a gel before buying a different enzyme.